BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11906615)

  • 1. Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre.
    Herold C; Reck T; Fischler P; Ott R; Radespiel-Troeger M; Ganslmayer M; Hohenberger W; Hahn EG; Schuppan D
    Liver; 2002 Feb; 22(1):23-8. PubMed ID: 11906615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognosis of hepatocellular carcinoma according to new staging classifications].
    Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of hepatocellular carcinoma in anti-HCV positive cirrhotic patients: a single-centre comparison amongst four different staging systems.
    Giannini E; Risso D; Botta F; Romagnoli P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Testa R
    J Intern Med; 2004 Mar; 255(3):399-408. PubMed ID: 14871465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular carcinoma in Austria: aetiological and clinical characteristics at presentation.
    Schöniger-Hekele M; Müller C; Kutilek M; Oesterreicher C; Ferenci P; Gangl A
    Eur J Gastroenterol Hepatol; 2000 Aug; 12(8):941-8. PubMed ID: 10958223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for survival in patients with compensated cirrhosis and small hepatocellular carcinoma after percutaneous ethanol injection therapy.
    Pompili M; Rapaccini GL; Covino M; Pignataro G; Caturelli E; Siena DA; Villani MR; Cedrone A; Gasbarrini G
    Cancer; 2001 Jul; 92(1):126-35. PubMed ID: 11443618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton beam therapy for hepatocellular carcinoma patients with severe cirrhosis.
    Hata M; Tokuuye K; Sugahara S; Fukumitsu N; Hashimoto T; Ohnishi K; Nemoto K; Ohara K; Matsuzaki Y; Akine Y
    Strahlenther Onkol; 2006 Dec; 182(12):713-20. PubMed ID: 17149578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the choice of treatment influence survival of patients with small hepatocellular carcinoma in compensated cirrhosis?
    Farinati F; Gianni S; Marin G; Fagiuoli S; Rinaldi M; Naccarato R
    Eur J Gastroenterol Hepatol; 2001 Oct; 13(10):1217-24. PubMed ID: 11711779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors and survival according to the Okuda stage in patients with hepatocellular carcinoma].
    Kim JH; Han SY; Kang AY; Shon YJ; Koo YH; Ryu SH; Cho JH; Han SH; Lee SW; Jang JS; Lee JH; Roh MH; Choi SR
    Korean J Gastroenterol; 2005 Oct; 46(4):283-90. PubMed ID: 16247272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease.
    Kemp W; Pianko S; Nguyen S; Bailey MJ; Roberts SK
    J Gastroenterol Hepatol; 2005 Jun; 20(6):873-81. PubMed ID: 15946134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients.
    Allgaier HP; Deibert P; Olschewski M; Spamer C; Blum U; Gerok W; Blum HE
    Int J Cancer; 1998 Dec; 79(6):601-5. PubMed ID: 9842968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options in Western hepatocellular carcinoma: a prospective study of 224 patients.
    Markovic S; Gadzijev E; Stabuc B; Croce LS; Masutti F; Surlan M; Berden P; Brencic E; Visnar-Perovic A; Sasso F; Ferlan-Marolt V; Mucelli FP; Cesar R; Sponza M; Tiribelli C
    J Hepatol; 1998 Oct; 29(4):650-9. PubMed ID: 9824276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
    Farinati F; Rinaldi M; Gianni S; Naccarato R
    Cancer; 2000 Dec; 89(11):2266-73. PubMed ID: 11147597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis.
    Schwartz ME; Sung M; Mor E; Fisher A; Popescu I; Fiel I; Sheiner P; Emre S; Guy S; Miller CM
    J Am Coll Surg; 1995 May; 180(5):596-603. PubMed ID: 7749537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trend of improving prognosis of hepatocellular carcinoma in clinical practice: an Italian in-field experience.
    Borzio M; Dionigi E; Rossini A; Toldi A; Francica G; Fornari F; Salmi A; Farinati F; Vicari S; Marignani M; Terracciano F; Ginanni B; Sacco R
    Dig Dis Sci; 2015 May; 60(5):1465-73. PubMed ID: 25399329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
    Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
    J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatocellular carcinoma: the significance of cirrhosis for treatment and prognosis--retrospective study].
    Witjes CD; de Man RA; Eskens FA; Dwarkasing RS; Zondervan PE; Verhoef C; Ijzermans JN
    Ned Tijdschr Geneeskd; 2010; 154():A1747. PubMed ID: 20719013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationality and effectiveness of transarterial chemoembolization as an initial treatment for BCLC B stage HBV-related hepatocellular carcinoma.
    Heng-jun G; Yao-jun Z; Min-shan C; Mei-xian C; Jun-ting H; Li X; Lau WY
    Liver Int; 2014 Apr; 34(4):612-20. PubMed ID: 24028297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of gemcitabine plus oxaliplatin in advanced hepatocellular carcinoma patients with Child-Pugh B cirrhosis.
    Dhooge M; Coriat R; Mir O; Perkins G; Brezault C; Boudou-Rouquette P; Goldwasser F; Chaussade S
    Oncology; 2013; 84(1):32-8. PubMed ID: 23076239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of nontransplant potentially curative therapy for early-stage hepatocellular carcinoma in Child-Pugh stage A cirrhosis is comparable with liver transplantation.
    Takahashi S; Kudo M; Chung H; Inoue T; Nagashima M; Kitai S; Tatsumi C; Minami Y; Ueshima K; Fukunaga T; Haji S
    Dig Dis; 2007; 25(4):303-9. PubMed ID: 17960064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.